• Je něco špatně v tomto záznamu ?

The Enhanced Recovery After Surgery protocol for the surgical management of craniosynostosis: Lausanne experience

A. Belouaer, G. Cossu, S. Al-Tayyari, A. Bubenikova, C. Caliman, F. Agri, MH. Perez, V. Chanez, Y. Boegli, C. Mury, RT. Daniel, M. Messerer

. 2023 ; 55 (6) : E14. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24000324

OBJECTIVE: Over the past decade, the Enhanced Recovery After Surgery (ERAS) program has demonstrated its effectiveness and efficiency in improving postoperative care and enhancing recovery across various surgical fields. Preliminary results of ERAS protocol implementation in craniosynostosis surgery are presented. METHODS: An ERAS protocol was developed and implemented for cranial pediatric neurosurgery, focusing on craniosynostosis repair. The study incorporated a pre-ERAS group consisting of a consecutive series of patients who underwent craniosynostosis repair surgery prior to the implementation of the ERAS protocol; the results were compared with a consecutive group of patients who had been prospectively collected since the introduction of the ERAS for craniosynostosis protocol. The safety, feasibility, and efficiency of the ERAS protocol in pediatric neurosurgery was evaluated, through the collection of clinical data from the pre-, intra-, and postoperative phase. Surgery-related complications were evaluated according to the Clavien-Dindo classification. Costs of the stays were obtained using a microcosting approach. RESULTS: A total of 35 pre-ERAS patients and 10 ERAS patients were included. Scaphocephaly was the most common pathology in both groups. The overall compliance with the pre-, intra-, and postoperative criteria significantly increased-from 35.5%, 64.4%, and 54.7%, respectively, in each phase to 94%, 90%, and 84% (p < 0.001). The authors noticed a reduction in the average opioid dose used per patient in the ERAS group (p = 0.004), and they observed a trend toward a decreased mean length of stay from 5.2 days in the pre-ERAS group to 4.6 days in the ERAS group, without an increase of the rate of readmission within 30 days of surgery. The rate of complications decreased but this difference was not statistically significant. The hospital costs lowered significantly: from 21,958 Confederatio Helvetica Francs (CHF) in the pre-ERAS group to 18,936 CHF in the ERAS group (p = 0.02). CONCLUSIONS: The ERAS protocol represents a safe and cost-effective tool for the perioperative management of craniosynostosis. It showed its positive impact on the analgesia provided and on the reduction of in-hospital costs for these patients. ERAS protocols may thus be interesting options in the pediatric neurosurgical field.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24000324
003      
CZ-PrNML
005      
20240213093116.0
007      
ta
008      
240109s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.3171/2023.9.FOCUS23540 $2 doi
035    __
$a (PubMed)38039522
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Belouaer, Amani $u 1Department of Clinical Neuroscience, Service of Neurosurgery, Lausanne University Hospital and University of Lausanne, Switzerland
245    14
$a The Enhanced Recovery After Surgery protocol for the surgical management of craniosynostosis: Lausanne experience / $c A. Belouaer, G. Cossu, S. Al-Tayyari, A. Bubenikova, C. Caliman, F. Agri, MH. Perez, V. Chanez, Y. Boegli, C. Mury, RT. Daniel, M. Messerer
520    9_
$a OBJECTIVE: Over the past decade, the Enhanced Recovery After Surgery (ERAS) program has demonstrated its effectiveness and efficiency in improving postoperative care and enhancing recovery across various surgical fields. Preliminary results of ERAS protocol implementation in craniosynostosis surgery are presented. METHODS: An ERAS protocol was developed and implemented for cranial pediatric neurosurgery, focusing on craniosynostosis repair. The study incorporated a pre-ERAS group consisting of a consecutive series of patients who underwent craniosynostosis repair surgery prior to the implementation of the ERAS protocol; the results were compared with a consecutive group of patients who had been prospectively collected since the introduction of the ERAS for craniosynostosis protocol. The safety, feasibility, and efficiency of the ERAS protocol in pediatric neurosurgery was evaluated, through the collection of clinical data from the pre-, intra-, and postoperative phase. Surgery-related complications were evaluated according to the Clavien-Dindo classification. Costs of the stays were obtained using a microcosting approach. RESULTS: A total of 35 pre-ERAS patients and 10 ERAS patients were included. Scaphocephaly was the most common pathology in both groups. The overall compliance with the pre-, intra-, and postoperative criteria significantly increased-from 35.5%, 64.4%, and 54.7%, respectively, in each phase to 94%, 90%, and 84% (p < 0.001). The authors noticed a reduction in the average opioid dose used per patient in the ERAS group (p = 0.004), and they observed a trend toward a decreased mean length of stay from 5.2 days in the pre-ERAS group to 4.6 days in the ERAS group, without an increase of the rate of readmission within 30 days of surgery. The rate of complications decreased but this difference was not statistically significant. The hospital costs lowered significantly: from 21,958 Confederatio Helvetica Francs (CHF) in the pre-ERAS group to 18,936 CHF in the ERAS group (p = 0.02). CONCLUSIONS: The ERAS protocol represents a safe and cost-effective tool for the perioperative management of craniosynostosis. It showed its positive impact on the analgesia provided and on the reduction of in-hospital costs for these patients. ERAS protocols may thus be interesting options in the pediatric neurosurgical field.
650    _2
$a lidé $7 D006801
650    _2
$a dítě $7 D002648
650    12
$a urychlená pooperační rehabilitace $7 D000080482
650    _2
$a pooperační komplikace $7 D011183
650    _2
$a pooperační péče $x metody $7 D011182
650    _2
$a nemocnice - náklady $7 D017721
650    12
$a kraniosynostózy $x chirurgie $7 D003398
650    _2
$a délka pobytu $7 D007902
655    _2
$a časopisecké články $7 D016428
700    1_
$a Cossu, Giulia $u 1Department of Clinical Neuroscience, Service of Neurosurgery, Lausanne University Hospital and University of Lausanne, Switzerland
700    1_
$a Al-Tayyari, Soulayma $u 1Department of Clinical Neuroscience, Service of Neurosurgery, Lausanne University Hospital and University of Lausanne, Switzerland
700    1_
$a Bubenikova, Adela $u 2Department of Neurosurgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Caliman, Catalina $u 1Department of Clinical Neuroscience, Service of Neurosurgery, Lausanne University Hospital and University of Lausanne, Switzerland
700    1_
$a Agri, Fabio $u 3Department of Administration and Finance, Lausanne University
700    1_
$a Perez, Maria-Helena $u 4Department of Pediatrics, Pediatric Intensive and Intermediate Care Units, Women-Mother-Child Department, Lausanne University Hospital and University of Lausanne; and
700    1_
$a Chanez, Vivianne $u 4Department of Pediatrics, Pediatric Intensive and Intermediate Care Units, Women-Mother-Child Department, Lausanne University Hospital and University of Lausanne; and
700    1_
$a Boegli, Yann $u 5Department of Anesthesiology, Pediatric Unit, Lausanne University Hospital and University of Lausanne, Switzerland
700    1_
$a Mury, Caroline $u 5Department of Anesthesiology, Pediatric Unit, Lausanne University Hospital and University of Lausanne, Switzerland
700    1_
$a Daniel, Roy Thomas $u 1Department of Clinical Neuroscience, Service of Neurosurgery, Lausanne University Hospital and University of Lausanne, Switzerland
700    1_
$a Messerer, Mahmoud $u 1Department of Clinical Neuroscience, Service of Neurosurgery, Lausanne University Hospital and University of Lausanne, Switzerland
773    0_
$w MED00008278 $t Neurosurgical focus $x 1092-0684 $g Roč. 55, č. 6 (2023), s. E14
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38039522 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213093113 $b ABA008
999    __
$a ok $b bmc $g 2049156 $s 1210018
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 55 $c 6 $d E14 $e - $i 1092-0684 $m Neurosurgical focus $n Neurosurg Focus $x MED00008278
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...